KENACORT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Kenacort, and when can generic versions of Kenacort launch?
Kenacort is a drug marketed by Delcor Asset Corp and is included in two NDAs.
The generic ingredient in KENACORT is triamcinolone. There are fifty-one drug master file entries for this compound. Additional details are available on the triamcinolone profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for KENACORT?
- What are the global sales for KENACORT?
- What is Average Wholesale Price for KENACORT?
Summary for KENACORT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 76 |
Clinical Trials: | 12 |
Formulation / Manufacturing: | see details |
DailyMed Link: | KENACORT at DailyMed |
![KENACORT drug patent expirations Drug patent expirations by year for KENACORT](/p/graph/s/t/KENACORT-patent-expirations.png)
Recent Clinical Trials for KENACORT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Sohag University | Phase 4 |
Assiut University | Phase 4 |
Kessler Foundation | Phase 2 |
US Patents and Regulatory Information for KENACORT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Delcor Asset Corp | KENACORT | triamcinolone diacetate | SYRUP;ORAL | 012515-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Delcor Asset Corp | KENACORT | triamcinolone | TABLET;ORAL | 011283-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Delcor Asset Corp | KENACORT | triamcinolone | TABLET;ORAL | 011283-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |